VERYFOL-5 TABLET

Composition:

L-Methylfolate Calcium 5 mg Tablets

Pack Type:

10 X 10

Short Discription:

Bioactive L-Methylfolate Calcium 5mg tablets for hyperhomocysteinemia, high-risk pregnancy, NTD prevention, and PMOS (formerly, PCOS) care.

VERYFOL-5 Tablets deliver a high-potency, biologically active form of folate as L-Methylfolate Calcium (5 mg). Unlike conventional synthetic folic acid, which requires a multi-step enzymatic conversion in the liver and gut, L-Methylfolate Calcium directly enters systemic circulation without relying on the methylenetetrahydrofolate reductase (MTHFR) enzyme. This high-dose therapeutic formulation is specifically engineered to overcome metabolic resistance, treat severe folate deficiencies, reduce toxic systemic homocysteine levels (hyperhomocysteinemia), and protect maternal-fetal microvasculature. It plays a crucial role in preventing recurrent pregnancy loss, safeguarding against neural tube defects (NTDs) in high-risk gestations, and supporting endocrine balance in women managing PMOS (formerly, PCOS).
  • Direct Cellular Availability (MTHFR Bypass): L-Methylfolate Calcium provides the active L-isomer form of folate (5-MTHF). It bypasses genetic defects or polymorphisms in the MTHFR enzyme, ensuring 100% bioavailability for immediate cellular utilization.
  • Homocysteine Remethylation: Acts as a key methyl donor in converting toxic homocysteine back to methionine. Lowering elevated homocysteine prevents vascular damage, placental thrombosis, and associated pregnancy complications.
  • DNA Synthesis & Neurodevelopment: Essential for purine and pyrimidine synthesis, facilitating rapid cell division, tissue growth, and proper neural tube closure during early fetal development.
  • Neurotransmitter & Endocrine Regulation: Serves as an essential cofactor in the synthesis of monoamine neurotransmitters (serotonin, dopamine, norepinephrine), supporting cognitive health, emotional well-being, and hormonal regulation in metabolic conditions like PMOS (formerly, PCOS).
  • Folate deficiency (Nutritional folate supplementation)
  • Pregnancy planning and prenatal folate supplementation
  • Prevention of Neural Tube Defects (NTDs) and recurrent pregnancy loss in high-risk gestations
  • Megaloblastic anemia resulting from severe folate deficiency
  • Hyperhomocysteinemia (elevated plasma homocysteine levels)
  • Patients with confirmed MTHFR gene mutations or folic acid conversion impairment
  • Adjuvant therapy in PMOS (formerly, PCOS) for metabolic and follicular support
  • Adjunctive management in Major Depressive Disorder (MDD) and mood dysfunction

Standard Dosage: One tablet (5 mg) daily, or as directed by the treating Physician or Gynaecologist.

Administration: Swallow the tablet whole with a glass of water, with or without food. Do not crush or chew.

To be taken strictly under medical supervision and diagnosis.